Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease
Fig 1
Comparison of cardiac troponin I levels.
Presented are patients with Fabry disease (FD) and left ventricular hypertrophy (LVH) (n = 17) versus FD patients without LVH (n = 18) and non-FD patients with LVH of other cause (n = 17). The cut-off level for cTnI in diagnosing myocardial infarction (≥0.04 ng/ml) is indicated in the figure.